TELIMRAX Trademark

Trademark Overview

On Friday, July 1, 2016, a trademark application was filed for TELIMRAX with the United States Patent and Trademark Office. The USPTO has given the TELIMRAX trademark a serial number of 87091219. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 3, 2020. This trademark is owned by Merck Sharp & Dohme Corp.. The TELIMRAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, anti-infectives and anti-virals
telimrax

General Information

Serial Number87091219
Word MarkTELIMRAX
Filing DateFriday, July 1, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 3, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 8, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, anti-infectives and anti-virals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 6, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck Sharp & Dohme Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889
Party NameMerck Sharp & Dohme Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889

Trademark Events

Event DateEvent Description
Monday, February 3, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 3, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 26, 2019EXTENSION 5 GRANTED
Monday, June 24, 2019EXTENSION 5 FILED
Wednesday, June 26, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 24, 2019TEAS EXTENSION RECEIVED
Saturday, December 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 6, 2018EXTENSION 4 GRANTED
Thursday, December 6, 2018EXTENSION 4 FILED
Thursday, December 6, 2018TEAS EXTENSION RECEIVED
Saturday, May 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 17, 2018EXTENSION 3 GRANTED
Thursday, May 17, 2018EXTENSION 3 FILED
Thursday, May 17, 2018TEAS EXTENSION RECEIVED
Thursday, November 30, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 28, 2017EXTENSION 2 GRANTED
Tuesday, November 28, 2017EXTENSION 2 FILED
Tuesday, November 28, 2017TEAS EXTENSION RECEIVED
Wednesday, June 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 12, 2017EXTENSION 1 GRANTED
Monday, June 12, 2017EXTENSION 1 FILED
Monday, June 12, 2017TEAS EXTENSION RECEIVED
Tuesday, January 3, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 8, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2016PUBLISHED FOR OPPOSITION
Wednesday, October 19, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 23, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 17, 2016ASSIGNED TO EXAMINER
Wednesday, July 6, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 5, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

telimrax anti infectives virals namely preparations pharmaceutical